# Microencapsulated Pomegranate Juice as Anti-Hypertensive

> **NCT07017296** · NA · COMPLETED · sponsor: **Universidad Autónoma del Estado de Hidalgo** · enrollment: 20 (actual)

## Conditions studied

- Clinical Trial

## Interventions

- **OTHER:** Placebo
- **DRUG:** Positive control
- **DIETARY_SUPPLEMENT:** Active comparator
- **DIETARY_SUPPLEMENT:** Control

## Key facts

- **NCT ID:** NCT07017296
- **Lead sponsor:** Universidad Autónoma del Estado de Hidalgo
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-15
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-05-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-06-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07017296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07017296, "Microencapsulated Pomegranate Juice as Anti-Hypertensive". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07017296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*